Papers
2
Total Citations
243
H-Index
2
About
Clayton Smith is a leading researcher in prostate cancer imaging and radiation oncology, with a primary focus on improving diagnostic accuracy and treatment outcomes for localized disease. His most impactful contribution is the development of a novel MRI grading system for assessing the risk of extraprostatic extension (EPE) of prostate cancer, detailed in his highly cited 2019 paper (238 citations). This work provides a standardized, non-invasive method to predict tumor spread beyond the prostate gland, directly aiding surgical planning and reducing the need for unnecessary aggressive interventions. Smith’s research also addresses critical gaps in post-treatment management, as seen in his 2020 study on managing isolated local failures following stereotactic body radiation therapy (SBRT). By identifying salvageable recurrence patterns, he helps refine strategies for patients with low to intermediate risk prostate cancer, ensuring that SBRT remains a safe and effective option. His work bridges radiology and oncology, offering practical tools for clinicians and improving patient stratification. Smith’s contributions are essential reading for anyone interested in precision medicine for prostate cancer, combining rigorous methodology with direct clinical applicability.
Research Focus
Key Achievements
Top Papers
- 1
- 2